Cargando…
A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery
BACKGROUND AND AIMS: A popliteal block is effective in managing postoperative pain for foot surgery, but since the duration of analgesia is limited following a single-shot popliteal fossa block technique, methods to prolong effective postoperative analgesia are mandatory. The aim of this study was t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863693/ https://www.ncbi.nlm.nih.gov/pubmed/27226733 http://dx.doi.org/10.2147/LRA.S96073 |
_version_ | 1782431518663114752 |
---|---|
author | Vermeylen, Kris De Puydt, Joris Engelen, Stefan Roofthooft, Eva Soetens, Filiep Neyrinck, Arne Van de Velde, Marc |
author_facet | Vermeylen, Kris De Puydt, Joris Engelen, Stefan Roofthooft, Eva Soetens, Filiep Neyrinck, Arne Van de Velde, Marc |
author_sort | Vermeylen, Kris |
collection | PubMed |
description | BACKGROUND AND AIMS: A popliteal block is effective in managing postoperative pain for foot surgery, but since the duration of analgesia is limited following a single-shot popliteal fossa block technique, methods to prolong effective postoperative analgesia are mandatory. The aim of this study was to assess the effect of adjuvants to ropivacaine on the duration of sensory and motor block. METHODS: In this double-blind randomized placebo-controlled study, we evaluated the analgesic effect of clonidine or dexamethasone (DXM) when added to ropivacaine for hallux valgus surgery. After obtaining institutional ethics research board approval and written informed consent, a total of 72 patients were randomly allocated. Fifty-seven of these patients were statistically analyzed. All patients received an ultrasound-guided single-shot popliteal fossa block with 30 mL of ropivacaine 0.75%, supplemented with saline, clonidine 100 µg, or DXM 5 mg. The primary end point was time to first pain sensation. Secondary end points were time to complete sensory and motor block regression. RESULTS: Compared to saline, duration to first pain sensation was prolonged by 9 hours (mean ± standard deviation: 31±9 hours) (42%) in the DXM group (P=0.024) and by 6 hours (28±10 hours) (27%) in the clonidine group (P=0.024). Compared to saline, DXM prolonged both complete sensory and motor blockade by 12 hours (25±7 hours) (46%) and 13 hours (36±6 hours) (55%), respectively, while clonidine prolonged complete sensory and motor blockade by 7 hours (30±7 hours) (27%) and 2 hours (22±5 hours) (10%), respectively. DXM prolonged sensory block regression time by 6 hours (21±7 hours) (41%) and clonidine by 2 hours (17±6 hours) (13%) compared to the control group (P=0.006). Similarly, DXM prolonged motor block regression by 7 hours (25±7 hours) (46%) and clonidine by 4 hours (21±4 hours) (19%) (P<0.0001). CONCLUSION: Addition of DXM and clonidine to ropivacaine significantly prolonged the duration of postoperative sensory and motor block. |
format | Online Article Text |
id | pubmed-4863693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-48636932016-05-25 A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery Vermeylen, Kris De Puydt, Joris Engelen, Stefan Roofthooft, Eva Soetens, Filiep Neyrinck, Arne Van de Velde, Marc Local Reg Anesth Original Research BACKGROUND AND AIMS: A popliteal block is effective in managing postoperative pain for foot surgery, but since the duration of analgesia is limited following a single-shot popliteal fossa block technique, methods to prolong effective postoperative analgesia are mandatory. The aim of this study was to assess the effect of adjuvants to ropivacaine on the duration of sensory and motor block. METHODS: In this double-blind randomized placebo-controlled study, we evaluated the analgesic effect of clonidine or dexamethasone (DXM) when added to ropivacaine for hallux valgus surgery. After obtaining institutional ethics research board approval and written informed consent, a total of 72 patients were randomly allocated. Fifty-seven of these patients were statistically analyzed. All patients received an ultrasound-guided single-shot popliteal fossa block with 30 mL of ropivacaine 0.75%, supplemented with saline, clonidine 100 µg, or DXM 5 mg. The primary end point was time to first pain sensation. Secondary end points were time to complete sensory and motor block regression. RESULTS: Compared to saline, duration to first pain sensation was prolonged by 9 hours (mean ± standard deviation: 31±9 hours) (42%) in the DXM group (P=0.024) and by 6 hours (28±10 hours) (27%) in the clonidine group (P=0.024). Compared to saline, DXM prolonged both complete sensory and motor blockade by 12 hours (25±7 hours) (46%) and 13 hours (36±6 hours) (55%), respectively, while clonidine prolonged complete sensory and motor blockade by 7 hours (30±7 hours) (27%) and 2 hours (22±5 hours) (10%), respectively. DXM prolonged sensory block regression time by 6 hours (21±7 hours) (41%) and clonidine by 2 hours (17±6 hours) (13%) compared to the control group (P=0.006). Similarly, DXM prolonged motor block regression by 7 hours (25±7 hours) (46%) and clonidine by 4 hours (21±4 hours) (19%) (P<0.0001). CONCLUSION: Addition of DXM and clonidine to ropivacaine significantly prolonged the duration of postoperative sensory and motor block. Dove Medical Press 2016-05-05 /pmc/articles/PMC4863693/ /pubmed/27226733 http://dx.doi.org/10.2147/LRA.S96073 Text en © 2016 Vermeylen et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Vermeylen, Kris De Puydt, Joris Engelen, Stefan Roofthooft, Eva Soetens, Filiep Neyrinck, Arne Van de Velde, Marc A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery |
title | A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery |
title_full | A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery |
title_fullStr | A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery |
title_full_unstemmed | A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery |
title_short | A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery |
title_sort | double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863693/ https://www.ncbi.nlm.nih.gov/pubmed/27226733 http://dx.doi.org/10.2147/LRA.S96073 |
work_keys_str_mv | AT vermeylenkris adoubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery AT depuydtjoris adoubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery AT engelenstefan adoubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery AT roofthoofteva adoubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery AT soetensfiliep adoubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery AT neyrinckarne adoubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery AT vandeveldemarc adoubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery AT vermeylenkris doubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery AT depuydtjoris doubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery AT engelenstefan doubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery AT roofthoofteva doubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery AT soetensfiliep doubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery AT neyrinckarne doubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery AT vandeveldemarc doubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery |